IQ-AI Ltd represents a corporate philosophy focused on advancing medical imaging technologies. The company values innovation, collaboration, and enhancing patient care through its cutting-edge solutions. By leveraging artificial intelligence, IQ-AI Ltd aims to improve the accuracy and efficiency of medical imaging interpretations. With a strong commitment to research and development, IQ-AI Ltd strives to continuously provide state-of-the-art imaging solutions for healthcare providers and patients alike. By combining expertise in medicine and AI, IQ-AI Ltd aims to revolutionize the field of medical imaging and contribute to the advancement of healthcare.

IQ-AI Ltd is primarily present in the United Kingdom and the United States.

IQ-AI Ltd has achieved several significant milestones in its journey. The company has successfully developed and commercially launched a range of innovative AI-based medical imaging software solutions. Notably, IQ-AI Ltd has achieved regulatory clearances for its products, demonstrating their safety and effectiveness. The company has also formed strategic partnerships with leading healthcare organizations, expanding their reach and impact in the medical imaging industry. Furthermore, IQ-AI Ltd has received notable recognition and awards for their cutting-edge technology and contributions to the field of medical imaging. These achievements highlight the company's commitment to driving advancements in healthcare through their AI-driven solutions.

IQ-AI Ltd, formerly known as Flying Brands Ltd, is a technology-focused UK-based company operating in the medical and health sector. Initially, the company specialized in selling flowers and other gifts online, but later transitioned into the healthcare industry. IQ-AI Ltd is currently engaged in developing and commercializing image analysis technologies for the medical and diagnostic imaging markets. With a strong focus on artificial intelligence and machine learning, IQ-AI Ltd aims to enhance medical professionals' ability to diagnose and monitor various conditions, including stroke and cancer. The company's dedication to technological advancements in the medical field positions them as a promising player in the healthcare industry.

IQ-AI Ltd operates in the medical imaging and diagnostics industry. Its main competitors in the market include leading companies such as Siemens Healthineers, General Electric Healthcare, and Koninklijke Philips N.V. These competitors also offer advanced medical imaging and diagnostic solutions, including MRI, CT, and PET technologies. However, IQ-AI Ltd differentiates itself by focusing on AI-powered software and image analysis solutions that enhance efficiency and accuracy in medical imaging interpretations. By leveraging its proprietary technologies, IQ-AI Ltd aims to provide innovative solutions that can revolutionize the medical imaging and diagnostics field.

IQ-AI Ltd is primarily active in the healthcare industry.

The business model of IQ-AI Ltd focuses on providing innovative medical imaging technologies and solutions. IQ-AI Ltd utilizes advanced artificial intelligence (AI) algorithms and software platforms to enhance diagnostic and treatment capabilities in various medical fields. By leveraging cutting-edge technology, IQ-AI Ltd aims to improve the accuracy and efficiency of medical imaging analysis, enabling healthcare professionals to make more informed decisions. With its focus on AI-driven solutions, IQ-AI Ltd aims to address the needs of medical institutions and contribute to improved patient outcomes.

Pašreizējais KGV IQ-AI nevar tikt aprēķināts.

KUV šobrīd IQ-AI nevar aprēķināt.

AlleAktien kvalitātes vērtējums IQ-AI ir 3/10.

Pašreiz nevar aprēķināt apgrozījumu IQ-AI.

Pašlaik peļņa IQ-AI nevar tikt aprēķināta.

IQ-AI Ltd is an innovative company specializing in the development of AI-based medical solutions. It consists of several divisions, each focusing on different application areas. One of the main divisions of IQ-AI is the development of image analysis software for radiology. They offer products that assist radiologists in interpreting medical images, such as software that automatically detects changes in X-ray images and enables quick and reliable diagnosis. Another division focuses on the development of AI-based medical devices, such as a system for automatic radiation blocking during CT scans, which can significantly reduce the radiation dose for patients. IQ-AI also specializes in developing software for medical research, offering solutions for more effective analysis of large amounts of data. Additionally, they provide tailored services, including consultation and training on their products. IQ-AI aims to develop and market comprehensive solutions for medical and research facilities, utilizing AI technologies to enable fast and accurate diagnoses and improve efficiency in healthcare. They also support medical research to enable new insights and therapies. In summary, IQ-AI Ltd is a company specializing in AI-based medical solutions. They offer comprehensive solutions for medical and research facilities through various divisions and products, utilizing the latest technologies and collaborating with the medical community to improve healthcare.

IQ-AI izmaksā dividendes 0 GBP, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt IQ-AI vai uzņēmums nedod dividendes.

IQ-AI ISIN ir JE00BD4H0R42.

IQ-AI WKN ir A2DSS6.

IQ-AI simbols ir IQAI.L.

Pēdējo 12 mēnešu laikā IQ-AI maksāja dividendes 0,01 GBP apmērā. Tas atbilst aptuveni 55,17 % dividendes ražībai. Nākamajos 12 mēnešos IQ-AI plāno maksāt dividendes 0 GBP apmērā.

IQ-AI pašreizējā dividendu rentabilitāte ir 55,17 %.

IQ-AI maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos septembris, maijs, septembris, maijs.

IQ-AI pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 GBP. Tas atbilst dividendes ražībai 0 %.

IQ-AI tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu IQ-AI apmērā 0,008 GBP, kas tika izmaksāta 5.05.2011., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 6.04.2011..

Pēdējās dividendes izmaksa notika 5.05.2011..

Gadā 2023, IQ-AI izmaksāja 0 GBP dividendes.

IQ-AI dividendes tiek izmaksātas GBP.